The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort by Barbara Ankli, Christoph T. Berger, Nicolas Haeni, Diego Kyburz, Thomas Hügle, Alexander K.-L. So, Thomas Daikeler

“…Patients followed up by rheumatologists reached the target serum uric acid at follow-up more often than those that were not (p = 0.033). …”
Get full text

Scleritis in rheumatoid arthritis: Before and during biologic era by Daphne P. C. Vergouwen, Daphne P. C. Vergouwen, Pascal H. P. de Jong, Marco W. J. Schreurs, Josianne C. Ten Berge, Aniki Rothova

“…Ophthalmologists and rheumatologists should be aware of scleritis as a severe extra-articular manifestation of RA.…”
Get full text

THE INCIDENCE OF MUSCULOSKELETAL DISEASES IN THE RUSSIAN FEDERATION OVER 2015–2016 by R. M. Balabanova, T. V. Dubinina, A. V. Demina, O. A. Krichevskaya

“…This is most likely to be associated with a shortage of trained rheumatologists in individual subjects of the Russian Federation. …”
Get full text

Multidisciplinary recommendations for diagnosis and treatment of foot problems in people with rheumatoid arthritis by Marloes Tenten-Diepenmaat, Marike van der Leeden, Thea P. M. Vliet Vlieland, Joost Dekker, on behalf of the RA Foot Expert Group

“…The expert group was composed of 2 patients and 22 experienced professionals (rheumatologists, rehabilitation physicians, orthopaedic surgeons, specialized nurses, podiatrists, orthopaedic shoe technicians, pedicurists, and researchers) in the Netherlands. …”
Get full text

RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer by Sang T. Kim, William A. Murphy Jr, Ana Aparicio, Sumit K. Subudhi

“…Conclusion: To the best of our knowledge, this is the first reported case of RS3PE after the combined second-generation hormonal therapy plus ipilimumab. Both rheumatologists and oncologists should be aware that RS3PE can develop as an irAE. …”
Get full text

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis by T. V. Beketova, E. A. Naryshkin, E. V. Arsenyev, M. A. Makarov

“…To reduce the risk of postoperative complications  (primarily thromboembolism, infections, and RTM-induced late-onset  neutropenia), total HA should be performed in the period of AASV remission under the control of comorbid conditions  and in the close cooperation  of rheumatologists  and orthopedic  surgeons. The following recommendations for the management of patients with rheumatic diseases should include patients with AASV for elective total HA.…”
Get full text

Detecting hand joint ankylosis and subluxation in radiographic images using deep learning: A step in the development of an automatic radiographic scoring system for joint destructi... by Keisuke Izumi, Kanata Suzuki, Masahiro Hashimoto, Toshio Endoh, Kentaro Doi, Yuki Iwai, Masahiro Jinzaki, Shigeru Ko, Tsutomu Takeuchi, Yuko Kaneko

“…Using our newly developed annotation tool, well-trained rheumatologists and radiologists labeled the mTSS to the wrist, metacarpal phalangeal joints, and proximal interphalangeal joints included in the images. …”
Get full text

90 Novel approach for childhood Sjögren’s Disease therapies: multistakeholder design of a series of N-of-1 trials by Nora G. Singer, Sara M Stern, Marisha E Palm, Harry Selker, Ludovic Trinquart

“…The Design Lab multi-stakeholder process involved parents of and patients with cSD, pediatric and adult rheumatologists, and experts in clinical trial design and outcomes. …”
Get full text

Hemophagocytic lymphohistiocytosis associated with herpes infection by G.S. Karpovich, A.E. Shestakov, E.I. Krasnova

“…For selecting an adequate therapy, it is necessary to conduct high-quality comprehensive diagnostic testing with the involvement of hematologists, rheumatologists. and oncologists. </p> <p> <b>Keywords: </b>hemophagocytic lymphohistiocytosis, infectious diseases, herpes virus, Epstein-Barr virus, cytomegalovirus, hematology, mixed infection. …”
Get full text

Safety and Effects of the Rapid Maxillary Expander on Temporomandibular Joint in Subjects Affected by Juvenile Idiopathic Arthritis: A Retrospective Study by Andrea Abate, Davide Cavagnetto, Francesca Maria Emilia Rusconi, Paolo Cressoni, Luca Esposito

“…Conclusions: Growing patients with JIA that ceased to show signs of active TMJ involvement for at least one year could be safely treated with RME, expecting similar benefits to those of healthy patients. Dentists and rheumatologists should be informed of safety and potential benefits of palatal expansion in JIA patients in order to improve the outcome of orthodontic treatment and reduce the indication for more invasive procedures (i.e., Surgical Assisted Rapid Maxillary Expansion).…”
Get full text

Probe into the clinical standardized training mode for refresher physicians in Rheumatic Immunology Department by ZHANG Shangzhu, LI Qingyang, LI Hailong, SU Jinmei, LI Mengtao, ZHANG Wen, ZENG Xiaofeng

“…The average improvement in the diagnosis and treatment level of rare diseases was 50.4%.There were 65.25% of the refresher physicians believed that the most rewarding learning was in the outpatient clinics, followed by discussion of difficult cases in wards and lectures by the fellowship physicians. 56.5% of the refresher physicians felt that the optimal duration of the advanced training was 12 months.Conclusions A comprehensive training system combining outpatient tutorials, case-based training of difficult cases in the ward, specialized lectures and multidisciplinary lectures for advanced refresher physicians is effective for training rheumatologists.…”
Get full text

The Result of Timely Therapy for Whipple's Disease: a Clinical Case by S. N. Mekhtiev, O. A. Mekhtieva, E. Yu. Kalinina, V. E. Karev, A. V. Vanyan, O. M. Berko

“…Whipple's disease is a rare systemic infectious disease that internists, gastroenterologists, rheumatologists, and other physicians may encounter. The incidence of Whipple's disease is extremely low and amounts to 1 case per 1,000,000–10,000,000 people. …”
Get full text

Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial by Zhaleh Shariati Sarabi, Mehran Ghazi Saeidi, Mandana Khodashahi, Ali Etemad Rezaie, Kamila Hashemzadeh, Rozita Khodashahi, Hossein Heidari

“…Response to treatment and the clinical status of patients were evaluated using the Disease Activity Score (DAS-28) and Visual Analogue Scale (VAS) at weeks zero, four, eight, and twelve, based on the 2010 ACR/EULAR Criteria by two rheumatologists. Disease activity and laboratory parameters, including erythrocyte sedimentation rate (ESR), high-sensitivity Creactive protein (hs-CRP), DAS-ESR, DAS- hs-CRP, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and liver function test (LFT) were measured in both groups. …”
Get full text

Outcomes following Adalimumab bio-originator to biosimilar switch - a comparison using real-world patient and physician reported data in European countries by Taylor, PC, Sanchez Gonzalez, Y, Clark, R, Faccin, F, Howell, O

“…<br><strong> Results<br></strong> Three hundred and three rheumatologists provided data for 160 non-switchers and 225 switchers, 140 patients provided data; 51 non-switchers, 89 switchers. …”

A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies Af... by Caporali, R, Kadakia, A, Howell, O, Patel, J, Milligan, J, Strengholt, S, Barlow, S, Taylor, PC

“…Methods: Data were drawn from the Adelphi RA Disease Specific Programme™, a cross-sectional survey administered to rheumatologists and their consulting patients in Germany, France, Italy, Spain, the UK, Japan, Canada, and the USA from May 2021 to January 2022. …”

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Smolen, J, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J, Hazes, J, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M, van der Heijde, D

“…These recommendations intend informing rheumatologists, patients, national rheumatology societies, hospital officials, social security agencies and regulators about EULAR’s most recent consensus on the management of RA, aimed at attaining best outcomes with current therapies.…”

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis by Singh, J, Guyatt, G, Ogdie, A, Gladman, D, Deal, C, Deodhar, A, Dubreuil, M, Dunham, J, Husni, M, Kenny, S, Kwan-Morley, J, Lin, J, Marchetta, P, Mease, P, Merola, J, Miner, J, Ritchlin, C, Siaton, B, Smith, B, Van Voorhees, A, Jonsson, A, Shah, A, Sullivan, N, Turgunbaev, M, Coates, L, Gottlieb, A, Magrey, M, Nowell, W, Orbai, A, Reddy, S, Scher, J, Siegel, E, Siegel, M, Walsh, J, Turner, A, Reston, J

“…A voting panel, including rheumatologists, dermatologists, other health professionals, and patients, achieved consensus on the direction and the strength of the recommendations.…”

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including... by Zhang, W, Doherty, M, Leeb, B, Alekseeva, L, Arden, N, Bijlsma, J, Dinçer, F, Dziedzic, K, Häuselmann, H, Herrero-Beaumont, G, Kaklamanis, P, Lohmander, S, Maheu, E, Martín-Mola, E, Pavelka, K, Punzi, L, Reiter, S, Sautner, J, Smolen, J, Verbruggen, G, Zimmermann-Górska, I

“…METHODS: The multidisciplinary guideline development group comprised 16 rheumatologists, one physiatrist, one orthopaedic surgeon, two allied health professionals, and one evidence based medicine expert, representing 15 different European countries. …”

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis by Singh, JA, Guyatt, G, Ogdie, A, Gladman, DD, Deal, C, Deodhar, A, Dubreuil, M, Dunham, J, Husni, ME, Kenny, S, Kwan-Morley, J, Lin, J, Marchetta, P, Mease, PJ, Merola, JF, Miner, J, Ritchlin, CT, Siaton, B, Smith, BJ, Voorhees, AS, Jonsson, AH, Shah, AA, Sullivan, N, Turgunbaev, M, Coates, LC, Gottlieb, A, Magrey, M, Nowell, WB, Orbai, AM, Reddy, SM, Scher, JU, Siegel, E, Siegel, M, Walsh, JA, Turner, AS, Reston, J

“…A voting panel, including rheumatologists, dermatologists, other health professionals, and patients, achieved consensus on the direction and the strength of the recommendations.…”

NET-RMDs study: networks of fatigue and pain in rheumatic and musculoskeletal diseases – protocol for an international cross-sectional study by Ricardo J O Ferreira, Marianne Visser, Blanca Gavilán-Carrera, Fernando Estévez-López, Joseph McVeigh, Rinie Geenen, Ciara Hughes, Lourdes Barbosa, Lynn Boschloo

“…These factors were derived from literature and identified by interviews with patients, health professionals and rheumatologists. Using this input, the steering committee of the project decided the factors to be measured giving priority to those that can be modified in self-management support in community health centres worldwide. …”
Get full text